PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: 9-Me-BC, 9-Methyl-beta-carboline
9-Me-BC (9-methyl-beta-carboline) is a small-molecule beta-carboline studied as a nootropic for its dopaminergic, neuroprotective, and neurogenesis-promoting effects in animal models.
Sign in to rate this peptide.
9-Me-BC is a beta-carboline alkaloid that acts as a mild monoamine oxidase inhibitor and increases dopaminergic activity, raising dopamine levels in the brain. In cell and rodent studies it stimulates the proliferation and maturation of dopaminergic neurons, upregulates neurotrophic factors, and exerts anti-inflammatory effects on glial cells. These combined actions are studied for cognitive enhancement and protection of dopaminergic systems relevant to learning and Parkinsonian models.